Ken Griffin
ENVB icon

Ken Griffin’s Enveric Biosciences ENVB Stock Holding History

Ken Griffin’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,890
Closed -$14.5K – 12987
2025
Q3 		$14.5K Buy
+1,890
New +$24.8K ﹤0.01% 12537
2025
Q2 		– Sell
-1,672
Closed -$27.9K – 13179
2025
Q1 		$27.9K Buy
1,672
+1,589
+1,914% +$55K ﹤0.01% 12889
2024
Q4 		$5.38K Buy
83
+12
+17% +$871 ﹤0.01% 13871
2024
Q3 		$6.04K Buy
+71
New +$6.53K ﹤0.01% 13448
2024
Q2 		– Sell
-223
Closed -$40.1K – 14526
2024
Q1 		$40.1K Buy
+223
New +$43K ﹤0.01% 12390
2023
Q3 		– Sell
-77
Closed -$47K – 14499
2023
Q2 		$47K Buy
+77
New +$37.5K ﹤0.01% 11873
2022
Q2 		– Sell
-6
Closed -$12.8K – 13154
2022
Q1 		$20K Sell
6
-11
-65% -$48.6K ﹤0.01% 13236
2021
Q4 		$144K Buy
17
+7
+70% +$98.4K ﹤0.01% 12314
2021
Q3 		$179K Buy
10
+9
+900% +$175K ﹤0.01% 12137
2021
Q2 		$31K Buy
+1
New +$21.4K ﹤0.01% 13476
2021
Q1 		– Sell
-1
Closed -$43K – 13278
2020
Q4 		$43K Buy
+1
New +$52.5K ﹤0.01% 10617
2019
Q4 		– Hold
0
– -$33K – 9263
2019
Q3 		– Hold
0
– – – 8822
2019
Q1 		– Hold
0
– -$2K – 9404
2018
Q4 		– Hold
0
– – – 8999

Other funds holding ENVB

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Ken Griffin's ENVB Position: Q4 2025 in Review

Ken Griffin sold out of Enveric Biosciences (ENVB) in Q4 2025, closing a stake of 1,890 shares — an estimated $14.5K sold.

Ken Griffin first reported a position in ENVB in Q4 2020 and held it in 11 quarters. The position peaked at $179K in Q3 2021. 11 funds tracked by Wall St. Rank hold ENVB as of Q4 2025.

  • Ken Griffin reported no remaining Enveric Biosciences position as of Q4 2025 after selling out during the quarter.
  • Ken Griffin sold 1,890 Enveric Biosciences shares in Q4 2025, an estimated $14.5K.
  • Ken Griffin first reported a position in Enveric Biosciences in Q4 2020 and held it in 11 quarters.
  • Ken Griffin's Enveric Biosciences position peaked at $179K in Q3 2021.
  • 11 funds tracked by Wall St. Rank held Enveric Biosciences as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.